Sorrento Therapeutics Inc. (SRNE): Price and Financial Metrics
SRNE Price/Volume Stats
| Current price | $0.00 | 52-week high | $0.02 |
| Prev. close | $0.00 | 52-week low | $0.00 |
| Day low | $0.00 | Volume | 122,391 |
| Day high | $0.00 | Avg. volume | 81,079 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 1.16M |
SRNE Stock Price Chart Interactive Chart >
Sorrento Therapeutics Inc. (SRNE) Company Bio
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
SRNE Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SRNE Price Returns
| 1-mo | 0.00% |
| 3-mo | 0.00% |
| 6-mo | 0.00% |
| 1-year | 0.00% |
| 3-year | 0.00% |
| 5-year | 0.00% |
| YTD | 0.00% |
| 2024 | -99.60% |
| 2023 | -86.06% |
| 2022 | -80.95% |
| 2021 | -31.87% |
| 2020 | 101.92% |